MEI Pharma Inc. Stock
Pros and Cons of MEI Pharma Inc. in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of MEI Pharma Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| MEI Pharma Inc. | - | - | - | - | - | - | - |
| Heron Therapeutics Inc. | 7.920% | 2.745% | 51.009% | -44.196% | -5.925% | -48.119% | -92.522% |
| Evolus Inc | 15.640% | 7.622% | 38.757% | -52.931% | -11.908% | -36.829% | -34.233% |
| Sangamo Therapeutics Inc. | 50.930% | -14.856% | -41.262% | -76.156% | -56.089% | -87.512% | -98.377% |
Comments
MEI Pharma (NASDAQ:MEIP) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Show more
Ratings data for MEIP provided by MarketBeat
MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for MEIP provided by MarketBeat
MEI Pharma, Inc. (NASDAQ: MEIP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for MEIP provided by MarketBeat